ADARx Pharmaceuticals, Inc. (ADRX) vs Braveheart Bio, Inc. (BRVE)

ADARx Pharmaceuticals, Inc. ADRX 17.52 +2.28%
Braveheart Bio, Inc. BRVE 21.35 +1.47%

ADARx Pharmaceuticals, Inc. and Braveheart Bio, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Braveheart Bio, Inc. are of similar size ($1.9B and $1.9B).

Metric	ADRX	BRVE	Biotechnology median
P/E	—	—	8.58
P/S	—	n/m	10.29
P/B	—	n/m	2.29
Price to free cash flow	—	n/m	21.93
EV/EBITDA	—	n/m	0.67
EV/Sales	—	n/m	9.89
Earnings yield	—	—	(31.56%)
Free cash flow yield	—	(14.01%)	(23.42%)

Metric	ADRX	BRVE	Biotechnology median
Gross margin	—	—	65.77%
Operating margin	—	0.00%	0.00%
Net margin	—	0.00%	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	0.00%	(54.09%)
Return on assets	—	0.00%	(47.78%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	BRVE	Biotechnology median
Revenue growth (TTM)	—	—	5.83%
EPS growth (last fiscal year)	—	—	29.36%
Revenue growth, 5-year CAGR	—	—	9.41%
Net income growth, 5-year CAGR	—	—	0.00%

Metric	ADRX	BRVE	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	13.63	4.80
Net debt to EBITDA	—	1.34	0.97

Metric	ADRX	BRVE	Biotechnology median
Dividend yield	—	—	0.44%
Payout ratio	—	—	—

Metric	ADRX	BRVE	Biotechnology median
Market cap	1.90b	1.89b	153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack